# Open Label, Healthy Volunteers, Bioequivalence Study With Naloxegol

> **NCT01623609** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 42 (actual)

## Conditions studied

- Opioid Induced Constipation

## Interventions

- **DRUG:** Naloxegol
- **DRUG:** Naloxegol

## Key facts

- **NCT ID:** NCT01623609
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2014-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01623609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01623609, "Open Label, Healthy Volunteers, Bioequivalence Study With Naloxegol". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01623609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*